Abstract
The incidence of calcium phosphate (CaP) stone disease has increased over the last three decades; specifically, brushite stones have been diagnosed and treated more frequently than in previous years. Brushite is a unique form of CaP, which in certain patients can form into large symptomatic stones. Treatment of brushite stones can be difficult since the stones are resistant to shock wave and ultrasonic lithotripsy, and often require ballistic fragmentation. Patients suffering from brushite stone disease are less likely to be rendered stone free after surgical intervention and often experience stone recurrence despite maximal medical intervention. Studies have demonstrated an association between brushite stone disease and shock wave lithotripsy (SWL) treatment. Some have theorized that many brushite stone formers started as routine calcium oxalate (CaOx) stone formers who sustained an injury to the nephron (such as SWL). The injury to the nephron leads to failure of urine acidification and eventual brushite stone formation. We explore the association between brushite stone disease and iatrogenic transformation of CaOx stone disease to brushite by reviewing the current literature.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- CaP:
-
Calcium phosphate
- SWL:
-
Shock wave lithotripsy
- RP:
-
Randall’s plaque
- CaOx:
-
Calcium oxalate
- PCNL:
-
Percutaneous nephrolithotomy
References
Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC (2003) Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int 63:1817–1823
Pearle MS, Calhoun EA, Curhan GC (2005) Urologic diseases in America project: urolithiasis. J Urol 173:848–857
Scales CD Jr, Curtis LH et al (2007) Changing gender prevalence of stone disease. J Urol 177:979–982
VanDervoort K, Wjesen J, Frank R, Vento S, Crosby V, Chandra M, Trachtman H (2007) Urolithiasis in pediatric patients: a single center study of incidence, clinical presentation and outcome. J Urol 177:2300–2305
Parks JH, Worcester EM, Coe FL, Evan AP, Lingeman JE (2004) Clinical implications of abundant calcium phosphate in routinely analyzed kidney stones. Kidney Int 66:777–785
Mandel N, Mandel I, Fryjoff K, Rejniak T, Mandel G (2003) Conversion of calcium oxalate to calcium phosphate with recurrent stone episodes. J Urol 169:2026–2029
Parks JH, Coe FL, Evan AP, Worcester EM (2009) Urine pH in renal calcium stone formers who do and do not increase stone phosphate content with time. Nephrol Dial Transplant 24:130–136
Matlaga BR, Kim SC, Watkins SL, Kuo RL, Munch LC, Lingeman JE (2006) Changing composition of renal calculi in patients with neurogenic bladder. J Urol 175:1716–1719
Pak CY, Poindexter JR, Adams-Huet B, Pearle MS (2003) Predictive value of kidney stone composition in the detection of metabolic abnormalities. Am J Med 115:26–32
Kuo RL, Moran ME, Kim DH, Abrahams HM, White MD, Lingeman JE (2002) Topiramate-induced nephrolithiasis. J Endourol 16:229–231
Matlaga BR, Coe FL, Evan AP, Lingeman JE (2007) The role of Randall’s plaques in the pathogenesis of calcium stones. J Urol 177:31–38
Neman WF, Toribara TY, Mulryan BJ (1962) Synthetic hydroxyapatite crystals. 1. Sodium and potassium fixation. Arch Biochem Biophys 98:384–390
Pak CY, Eanes ED, Ruskin B (1971) Spontaneous precipitation of brushite in urine: evidence that brushite is the nidus of renal stones originating as calcium phosphate. Proc Nat Acad Sci 68:1456–1460
Krambeck AE, Handa SE, Coe FL, Worchester EM, Evan AP, Lingeman JE (2010) Profile of the brushite stone former. J Urol (Under review)
Gault MH, Parfrey PS, Robertson WG (1988) Idiopathic calcium phosphate nephrolithiasis. Nephron 48:265–273
Evan AP, Lingeman JE, Coe FL, Shao Y, Parks JH, Bledsoe SB et al (2005) Crystal-associated nephropathy in patients with brushite nephrolithiasis. Kidney Int 67:576–591
Klee LW, Brito CG, Lingeman JE (1991) The clinical implications of brushite calculi. J Urol 145:715–718
Heimbach D, Jacobs D, Hesse A, Muller SC, Zhong P, Preminger GM (1999) How to improve lithotripsy and chemolitholysis of brushite-stones: an in vitro study. Urol Res 27:266–271
Kacker R, Meeks JJ, Zhao L, Nadler RB (2008) Decreased stone-free rates after percutaneous nephrolithotomy for high calcium phosphate composition kidney stones. J Urol 180:958–960
Kuo RL, Lingeman JE, Evan AP, Paterson RF, Parks JH, Bledsoe SB et al (2003) Urine calcium and volume predict coverage of renal papilla by Randall’s plaque. Kidney Int 64:2150–2155
Kaude JV, Williams CM, Millner MR, Scott KN, Finlayson B (1985) Renal morphology and function immediately after extracorporeal shock wave lithotripsy. Am J Roentgenol 145:305–313
Connors BA, Evan AP, Willis LR, Blomgren PM, Lingeman JE, Fineberg NS (2000) The effect of discharge voltage on renal injury and impairment caused by lithotripsy in the pig. J Am Soc Nephrol 11:310–318
Evan AP, Willis LR, Lingeman JE, McAteer JA (1998) Renal trauma and the risk of long-term complications in shock wave lithotripsy. Nephron 78:1–8
Hamm LL, Alpern R (1980) Cellular mechanisms of renal tubular acidification. In: Seldin DW, Giebisch G (eds) The kidney: physiology and pathophysiology, 2nd edn. Raven Press, New York, p 2581
Krambeck AE, Gettman MT, Rohlinger AL, Lohse CM, Patterson DE, Segura JW (2006) Diabetes mellitus and hypertension associated with shock wave lithotripsy at 19 years follow-up. J Urol 175:1742–1747
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Krambeck, A.E., Handa, S.E., Evan, A.P. et al. Brushite stone disease as a consequence of lithotripsy?. Urol Res 38, 293–299 (2010). https://doi.org/10.1007/s00240-010-0289-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00240-010-0289-y